×
About 154,390 results

ALLMedicine Asthma Center

Research & Reviews  68,795 results

Outside-in hypothesis revisited: the role of microbial, epithelial and immune interacti...
https://doi.org/10.1016/j.anai.2020.05.016
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology; Sugita K, Soyka MB et. al.

May 26th, 2020 - Our understanding of the origin of allergic diseases has increased in recent years, highlighting the importance of microbial dysbiosis and epithelial barrier dysfunction in affected tissues. Exploring the microbial-epithelial-immune crosstalk unde...

Immune semaphorins: Crucial regulatory signals and novel therapeutic targets in asthma ...
https://doi.org/10.1016/j.ejphar.2020.173209
European Journal of Pharmacology; Kalmarzi RN, Rajabinejad M et. al.

May 26th, 2020 - Asthma and allergic diseases are a group of chronic inflammatory disorders that arise as a result of excessive responses of the immune system against intrinsically harmless environmental substances. It is well known that substantial joint characte...

Treating asthma in the age of biologics.
https://doi.org/10.1097/01.JAA.0000657220.41861.2d
JAAPA : Official Journal of the American Academy of Physician Assistants; Prabakaran A

May 26th, 2020 - Many patients with severe asthma continue to have high symptom burden despite maximization of conventional therapy. As the understanding of asthma pathophysiology has evolved, however, more personalized therapy options have become available. Asthm...

YiQi GuBen Formula Inhibits PDGF-BB-Induced Proliferation and Migration of Airway Smoot...
https://doi.org/10.1159/000504516
Pharmacology Kong Y, Ding L et. al.

May 26th, 2020 - Increased proliferation and migration of airway smooth muscle cells (ASMCs) are key events in the development of asthma. YiQi GuBen is a traditional Chinese medicinal formula shown to effectively reduce the recurrence rate of asthma and induce ant...

Retrospective analysis of epidemic thunderstorm asthma in children in Yulin, northwest ...
https://doi.org/10.1038/s41390-020-0980-9
Pediatric Research; Xu YY, Xue T et. al.

May 26th, 2020 - An epidemic of thunderstorm asthma in pediatric patients occurred in Yulin, a northwest city of China, on 11 September 2018. We described the epidemic and retrospectively analyzed the demographic and clinical aspects of the involved children. The ...

see more →

Guidelines  243 results

Office Spirometry: Indications and Interpretation
https://www.aafp.org/afp/2020/0315/p362.html
American Family Physician; Langan RC,et al

Mar 14th, 2020 - Approximately 1% to 4% of all visits to primary care offices are for dyspnea.1 The proper use of pulmonary function tests can help differentiate many of the causes of dyspnea, monitor the progression of chronic pulmonary disease, and assess respon...

Managing Chronic Cough due to Asthma and NAEB in Adults and Adolescents: CHEST Expert P...
https://doi.org/10.1016/j.chest.2019.12.021
Chest Côté A, Russell RJ et. al.

Jan 23rd, 2020 - Asthma and non-asthmatic eosinophilic bronchitis (NAEB) are among the commonest causes of chronic cough in adults. We sought to determine the role of non-invasive measurements of airway inflammation, including induced sputum and fractional exhaled...

Asthma in Adults
https://www.sciencedirect.com/science/article/abs/pii/S0025712519300896?via%3Dihub
Medical Clinics of North America; Nanda A,et al

Oct 27th, 2019 - Asthma affects approximately 300 million people worldwide and approximately 7.5% of adults in the United States. Among adults, asthma results in about 10.5 million physician office visits per year and affects approximately 8.7% of blacks, 7.6% of ...

Genentech Announces FDA Approval of Xofluza (Baloxavir Marboxil) for People at High Risk of Developing Influenza-Related Complications
https://www.gene.com/media/press-releases/14817/2019-10-17/genentech-announces-fda-approval-of-xofl

Oct 16th, 2019 - Single-dose Xofluza is the first and only antiviral medicine indicated specifically for patients at high risk of developing serious complications from influenza (flu) The Centers for Disease Control and Prevention (CDC) defines people at high ris...

Global Initiative for Asthma: Global Strategy for Asthma Management & Prevention
https://ginasthma.org/wp-content/uploads/2019/06/GINA-2019-main-report-June-2019-wms.pdf

Sep 29th, 2019 - The 2019 update of the Global Strategy for Asthma Management and Prevention incorporates new scientific information about asthma based on a review of recent scientific literature by an international panel of experts on the GINA Science Committee. ...

see more →

Drugs  1,155 results see all →

Clinicaltrials.gov  76,269 results

Outside-in hypothesis revisited: the role of microbial, epithelial and immune interacti...
https://doi.org/10.1016/j.anai.2020.05.016
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology; Sugita K, Soyka MB et. al.

May 26th, 2020 - Our understanding of the origin of allergic diseases has increased in recent years, highlighting the importance of microbial dysbiosis and epithelial barrier dysfunction in affected tissues. Exploring the microbial-epithelial-immune crosstalk unde...

Immune semaphorins: Crucial regulatory signals and novel therapeutic targets in asthma ...
https://doi.org/10.1016/j.ejphar.2020.173209
European Journal of Pharmacology; Kalmarzi RN, Rajabinejad M et. al.

May 26th, 2020 - Asthma and allergic diseases are a group of chronic inflammatory disorders that arise as a result of excessive responses of the immune system against intrinsically harmless environmental substances. It is well known that substantial joint characte...

Treating asthma in the age of biologics.
https://doi.org/10.1097/01.JAA.0000657220.41861.2d
JAAPA : Official Journal of the American Academy of Physician Assistants; Prabakaran A

May 26th, 2020 - Many patients with severe asthma continue to have high symptom burden despite maximization of conventional therapy. As the understanding of asthma pathophysiology has evolved, however, more personalized therapy options have become available. Asthm...

YiQi GuBen Formula Inhibits PDGF-BB-Induced Proliferation and Migration of Airway Smoot...
https://doi.org/10.1159/000504516
Pharmacology Kong Y, Ding L et. al.

May 26th, 2020 - Increased proliferation and migration of airway smooth muscle cells (ASMCs) are key events in the development of asthma. YiQi GuBen is a traditional Chinese medicinal formula shown to effectively reduce the recurrence rate of asthma and induce ant...

Retrospective analysis of epidemic thunderstorm asthma in children in Yulin, northwest ...
https://doi.org/10.1038/s41390-020-0980-9
Pediatric Research; Xu YY, Xue T et. al.

May 26th, 2020 - An epidemic of thunderstorm asthma in pediatric patients occurred in Yulin, a northwest city of China, on 11 September 2018. We described the epidemic and retrospectively analyzed the demographic and clinical aspects of the involved children. The ...

see more →

News  7,631 results

Asthma Prolongs Intubation Time in COVID-19 Patients
https://www.medscape.com/viewarticle/931003

May 25th, 2020 - NEW YORK (Reuters Health) - Asthma may prolong the time a person hospitalized with COVID-19 is on a ventilator, a new study suggests. "Although asthmatics might not be at higher risk to acquire the virus, once they do, asthmatics have a significan...

Asthma Patients Advised to Continue Therapy During Pandemic
https://www.medscape.com/viewarticle/930648

May 15th, 2020 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's  Coronavirus Resource Center. An allergist and a pediatric pulmonologist cautioned colleagues that COVID-19 could be spawning hazardous behavior as patients question whether t...

Eosinophilic Esophagitis Management Clinical Practice Guidelines (AGA/JTF, 2020)
https://www.medscape.com/viewarticle/930042

May 10th, 2020 - In May 2020, the American Gastroenterological Association (AGA) Institute and the Joint Task Force on Practice Parameters (JTF) from the American Academy of Allergy, Asthma & Immunology/American College of Allergy, Asthma & Immunology issued clini...

EU Panel Backs First Triple Combo Asthma Inhaler With Digital Sensor
https://www.medscape.com/viewarticle/930037

May 5th, 2020 - The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended approval of Enerzair Breezhaler, the first triple-combination asthma therapy that includes an optional digital sensor. Enerzair Breezh...

US Starts Study to Find COVID-19 Infection Rate in Children
https://www.medscape.com/viewarticle/929885

May 4th, 2020 - (Reuters) - The National Institutes of Health said on Monday it has started enrolling participants in a study to find out the infection rate of COVID-19, caused by the new coronavirus, in children and their families in the United States. The gover...

see more →

Patient Education  297 results see all →